CDKN1B and cancer: Intriguingly, we also established the improved efficacy of MLN4924 by P27 knockdown in in vivo studies based on the zebrafish xenograft model,29, 33 and found this sensitization by P27 silencing might be applied in other cancers as well (Supplementary Figure S4).